CLINICAL_TRIALS
trial_result
· 2025-04-11
Clinical Trial Update: Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma
Summary
A completed clinical trial update presenting results from a survey of cabozantinib use in patients with renal cell carcinoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Renal Cell Carcinoma | Status: COMPLETED | Results posted: 2025-04-11